Browse All

Current Filters

CLEAR FILTER x

TITLE

An Observational Study of Prion Disease

Author:Yarlagadda, Sushuma   Corbali, Osman   Persico, Michele   Cavanagh, Julien   Siddu, Mithilesh   Hutto, Spencer   Greene, James   Jillella, Dinesh   

Session Name:P8: Infectious Disease: Clinical Cases of PML, HIV, and Non-conventional Infectious Agents with Diagnostic Insights 2  

Topic:Infectious Disease  

Program Number:P8.005  

Author Institution:Emory University, Atlanta, GA  Emory University School of Medicine / Grady Memorial Hospital, Atlanta, GA  

Obstructive Sleep Apnea is a Risk Factor for Parkinson’s Disease and CPAP Mitigates Risk of PD: An EHR-based Cohort Study in Military Veterans

Author:Montano, Isabella   May, Jasmine L.   Neilson, Lee   Cho, Yeilim   Iliff, Jeffrey   Elliott, Jonathan E.   Scott, Gregory   Lim, Miranda   

Session Name:PL4: Contemporary Clinical Issues Plenary Session  

Topic:Sleep  

Program Number:PL4.005  

Author Institution:VA Portland Health Care System, Portland, OR  

Occam’s Razor or Hickam’s Dictum: GAD65 Temporal Lobe Epilepsy with Subsequent Movement Disorder and Coincidental Mutations in the VPS13A Gene

Author:Freeman, Shelby   Hubacek, Sara   Vasudhar, Ananya   Walker, Lauren   Selioutski, Olga   Mahadeen, Ahmad   

Session Name:P2: Autoimmune Neurology: Stiff Person Syndrome  

Topic:Autoimmune Neurology  

Program Number:P2.012  

Author Institution:University of Mississippi Medical Center, Jackson, MS  

Occipital Nerve Block May be Helpful for the Treatment of BPPV Patients with Cervicalgia

Author:Zhang, Lily   Blackwell, Cora   Zhang, Lixin   

Session Name:P2: Neuro-ophthalmology/Neuro-otology: Eye Movement Disorders and Neuro-otology  

Topic:Neuro-ophthalmology/Neuro-otology  

Program Number:P2.013  

Author Institution:Dent Neurologic Institute, Amherst, NY  

Ocrelizumab Subcutaneous Administration: Further Characterization of the Benefit–Risk Profile from the OCARINA II Study and Patient Preferences

Author:Newsome, Scott   Goldstick, Lawrence   Selmaj, Krzysztof   Krzystanek, Ewa   Zecevic, Dusanka   Figueiredo, Catarina   Clinch, Susanne   Giacobino, Caroline   Azmi, Jay   Centonze, Diego   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.003  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD, USA, Baltimore, MD  Department of Neurology and Rehabilitation Waddell Center for Multiple Sclerosis, University of Cincinnati, College of Medicine, Cincinnati, OH, USA, Cincinnati, OH  Centrum Neurologii, Lódz, Poland, Lódz, Poland  Department of Neurology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland, Katowice, Poland  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy, Rome, Italy